These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35924947)

  • 1. Human microbiota colonization and pancreatic ductal carcinoma.
    Fang Y; Yang G; Yang J; Ren J; You L; Zhao Y
    Crit Rev Microbiol; 2023 Aug; 49(4):455-468. PubMed ID: 35924947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiome and pancreatic ductal adenocarcinoma.
    Tijeras-Raballand A; Hilmi M; Astorgues-Xerri L; Nicolle R; Bièche I; Neuzillet C
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101589. PubMed ID: 33607375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor Microbiome Analysis Identifies Positive Association Between
    Huang Y; Zhu N; Zheng X; Liu Y; Lu H; Yin X; Hao H; Tan Y; Wang D; Hu H; Liang Y; Li X; Hu Z; Yin Y
    Front Immunol; 2022; 13():785422. PubMed ID: 35145519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics.
    Qian J; Zhang X; Wei B; Tang Z; Zhang B
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188943. PubMed ID: 37355177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microbiome in pancreatic cancer.
    Li JJ; Zhu M; Kashyap PC; Chia N; Tran NH; McWilliams RR; Bekaii-Saab TS; Ma WW
    Cancer Metastasis Rev; 2021 Sep; 40(3):777-789. PubMed ID: 34455517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic ductal adenocarcinoma: Emerging therapeutic strategies.
    Osei-Bordom DC; Serifis N; Brown ZJ; Hewitt DB; Lawal G; Sachdeva G; Cloonan DJ; Pawlik TM
    Surg Oncol; 2022 Aug; 43():101803. PubMed ID: 35830772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of microbiota in pancreatic cancer development and treatment.
    Cruz MS; Tintelnot J; Gagliani N
    Gut Microbes; 2024; 16(1):2320280. PubMed ID: 38411395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients.
    Sammallahti H; Kokkola A; Rezasoltani S; Ghanbari R; Asadzadeh Aghdaei H; Knuutila S; Puolakkainen P; Sarhadi VK
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unraveling the gut microbiome's contribution to pancreatic ductal adenocarcinoma: mechanistic insights and therapeutic perspectives.
    Tabrizi E; Pourteymour Fard Tabrizi F; Mahmoud Khaled G; Sestito MP; Jamie S; Boone BA
    Front Immunol; 2024; 15():1434771. PubMed ID: 39044834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects.
    Nsingwane Z; Candy G; Devar J; Omoshoro-Jones J; Smith M; Nweke E
    Mol Biol Rep; 2020 Aug; 47(8):6269-6280. PubMed ID: 32661873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma.
    Ciernikova S; Novisedlakova M; Cholujova D; Stevurkova V; Mego M
    Biomedicines; 2020 Dec; 8(12):. PubMed ID: 33287196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective.
    Panebianco C; Ciardiello D; Villani A; Maiorano BA; Latiano TP; Maiello E; Perri F; Pazienza V
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):997-1007. PubMed ID: 34838957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview.
    Panchal K; Sahoo RK; Gupta U; Chaurasiya A
    Int Immunopharmacol; 2021 Jun; 95():107508. PubMed ID: 33725635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microbiota and microbiota-derived short-chain fatty acids in PDAC.
    Temel HY; Kaymak Ö; Kaplan S; Bahcivanci B; Gkoutos GV; Acharjee A
    Cancer Med; 2023 Mar; 12(5):5661-5675. PubMed ID: 36205023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.
    Orth M; Metzger P; Gerum S; Mayerle J; Schneider G; Belka C; Schnurr M; Lauber K
    Radiat Oncol; 2019 Aug; 14(1):141. PubMed ID: 31395068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.
    Yu Q; Newsome RC; Beveridge M; Hernandez MC; Gharaibeh RZ; Jobin C; Thomas RM
    Gut Microbes; 2022; 14(1):2112881. PubMed ID: 35980869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review.
    Brind'Amour A; Webb M; Parapini M; Sidéris L; Segedi M; Chung SW; Chartier-Plante S; Dubé P; Scudamore CH; Kim PTW
    Clin Exp Metastasis; 2021 Apr; 38(2):187-196. PubMed ID: 33486670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review).
    Huang X; Li M; Hou S; Tian B
    Int J Oncol; 2021 Dec; 59(6):. PubMed ID: 34738624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of the microbiome in the development and treatment of pancreatic cancer: Thinking outside of the box by looking inside the gut.
    Yu Q; Jobin C; Thomas RM
    Neoplasia; 2021 Feb; 23(2):246-256. PubMed ID: 33418277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.